The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
Open accessAbstract
Broadly neutralizing monoclonal antibodies (MAbs) are potentially important tools in human immunodeficiency virus type 1 (HIV-1) vaccine design. A few rare MAbs have been intensively studied, but we still have a limited appreciation of their neutralization breadth. Using a pseudovirus assay, we evaluated MAbs from clade B-infected donors and a clade B HIV+plasma against 93 viruses from diverse backgrounds. Anti-gp120 MAbs exhibited greater activity against clade B than non-B viruses, whereas anti-gp41 MAbs exhibited broad interclade activity. Unexpectedly, MAb 4E10 (directed against the C terminus of the gp41 ectodomain) neutralized all 90 viruses with moderate potency. MAb 2F5 (directed against an epitope adjacent to that of 4E10) neutralized 67% of isolates, but none from clade C. Anti-gp120 MAb b12 (directed against an epitope overlapping the CD4 binding site) neutralized 50% of viruses, including some from almost every clade. 2G12 (directed against a high-mannose epitope on gp120) neutralized 41% of the viruses, but none from clades C or E. MAbs to the gp120 V3 loop, including 447-52D, neutralized a subset of clade B viruses (up to 45%) but infrequently neutralized other clades (≤7%). MAbs b6 (directed against the CD4 binding site) and X5 (directed against a CD4-induced epitope of gp120) neutralized only sensitive primary clade B viruses. The HIV+plasma neutralized 70% of the viruses, including some from all major clades. Further analysis revealed five neutralizing immunotypes that were somewhat associated with clades. As well as the significance for vaccine design, our data have implications for passive-immunization studies in countries where clade C viruses are common, given that only MAbs b12 and 4E10 were effective against viruses from this clade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
The Elements of Statistical Learning
Hastie, T., Friedman, J., & Tibshirani, R. (2001) · Springer Series in Statistics · doi:10.1007/978-0-387-21606-5 · Cited by 24,162
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Lole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W., & Ray, S. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.152-160.1999 · Cited by 2,695
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Self-citationRapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Self-citationCD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Self-citationEfficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Self-citationCD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Self-citationA conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Self-citationRobertson, D. L., Anderson, J. P., Bradac, J. A., Carr, J. K., Foley, B., Funkhouser, R. K., Gao, F., Hahn, B. H., Kalish, M. L., Kuiken, C., et al. (2000) · Science · doi:10.1126/science.288.5463.55d · Cited by 964
Self-citationHuman Retroviruses and Aids - 1999
Kuiken, C., & Foley, B. (1999) · doi:10.2172/1186019 · Cited by 952
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., & Wilson, I. A. (2001) · Science · doi:10.1126/science.1061692 · Cited by 942
Self-citationShankarappa, R., Margolick, J. B., Gange, S. J., Rodrigo, A. G., Upchurch, D., Farzadegan, H., Gupta, P., Rinaldo, C. R., Learn, G. H., He, X., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10489-10502.1999 · Cited by 926
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Self-citationBaba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L. A., Posner, M. R., Katinger, H., Stiegler, G., et al. (2000) · Nature Medicine · doi:10.1038/72309 · Cited by 849
Self-citationDiversity Considerations in HIV-1 Vaccine Selection
Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., et al. (2002) · Science · doi:10.1126/science.1070441 · Cited by 811
Self-citationZwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Self-citationMascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Self-citationAntibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Self-citationScanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Self-citationBurton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
Self-citationParren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 662
Self-citationA Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1
Petropoulos, C. J., Parkin, N. T., Limoli, K. L., Lie, Y., Wrin, T., Huang, W., Tian, H., Smith, D., Winslow, G. A., Capon, D. J., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.920-928.2000 · Cited by 646
Self-citationAntibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
Self-citationDissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Moore, J. P., McKeating, J. A., Weiss, R. A., & Sattentau, Q. J. (1990) · Science · doi:10.1126/science.2251501 · Cited by 576
O'Brien, W. A., Koyanagi, Y., Namazie, A., Zhao, J.-Q., Diagne, A., ldler, K., Zack, J. A., & Chen, I. S. Y. (1990) · Nature · doi:10.1038/348069a0 · Cited by 570
Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus
Bubić, I., Wagner, M., Krmpotić, A., Saulig, T., Kim, S., Yokoyama, W. M., Jonjić, S., & Koszinowski, U. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7536-7544.2004 · Cited by 569
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Self-citationBUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Self-citationStiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., & Katinger, H. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220152741450 · Cited by 517
Self-citationZhang, M. (2004) · Glycobiology · doi:10.1093/glycob/cwh106 · Cited by 483
Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
Self-citationRoben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
Self-citationMascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.340 · Cited by 436
Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pöhlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252469399 · Cited by 404
Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.101-109.1995 · Cited by 401
Self-citationLabrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Self-citationA Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
PURTSCHER, M., TRKOLA, A., GRUBER, G., BUCHACHER, A., PREDL, R., STEINDL, F., TAUER, C., BERGER, R., BARRETT, N., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1651 · Cited by 347
Self-citationGorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Emini, E. A., Koenig, S., & Zolla-Pazner, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7538-7542.1992 · Cited by 308
Self-citationMoore, J. P., & Sodroski, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1863-1872.1996 · Cited by 304
Muster, T., Guinea, R., Trkola, A., Purtscher, M., Klima, A., Steindl, F., Palese, P., & Katinger, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4031-4034.1994 · Cited by 286
Self-citationGao, F., Morrison, S. G., Robertson, D. L., Thornton, C. L., Craig, S., Karlsson, G., Sodroski, J., Morgado, M., Galvao-Castro, B., von Briesen, H., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1651-1667.1996 · Cited by 285
Understanding the genetic diversity of HIV-1.
McCutchan, F. E. (2000) · PubMed · Cited by 270
Gauduin, M.-C., Parren, P. W. H. I., Weir, R., Barbas, C. F., Burton, D. R., & Koup, R. A. (1997) · Nature Medicine · doi:10.1038/nm1297-1389 · Cited by 258
Self-citationCheng-Mayer, C., Quiroga, M., Tung, J. W., Dina, D., & Levy, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4390-4398.1990 · Cited by 251
Cormier, E. G., & Dragic, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8953-8957.2002 · Cited by 251
The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
Parren, P. W. H. I., Moore, J. P., Burton, D. R., & Sattentau, Q. J. (1999) · PubMed · Cited by 248
Self-citationMoore, J. P., Sattentau, Q. J., Wyatt, R., & Sodroski, J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.469-484.1994 · Cited by 248
McMichael, A. J., & Hanke, T. (2003) · Nature Medicine · doi:10.1038/nm0703-874 · Cited by 240
Quiñones-Mateu, M. E., Ball, S. C., Marozsan, A. J., Torre, V. S., Albright, J. L., Vanham, G., van der Groen, G., Colebunders, R. L., & Arts, E. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9222-9233.2000 · Cited by 234
Moog, C., Fleury, H. J., Pellegrin, I., Kirn, A., & Aubertin, A. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3734-3741.1997 · Cited by 232
Moore, J. P., Cao, Y., Leu, J., Qin, L., Korber, B., & Ho, D. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.427-444.1996 · Cited by 221
Self-citationBarnett, S. W., Lu, S., Srivastava, I., Cherpelis, S., Gettie, A., Blanchard, J., Wang, S., Mboudjeka, I., Leung, L., Lian, Y., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5526-5540.2001 · Cited by 216
Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., & Moss, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3015-3026.1994 · Cited by 215
Conley, A. J., Gorny, M. K., Kessler, J. A., Boots, L. J., Ossorio-Castro, M., Koenig, S., Lineberger, D. W., Emini, E. A., Williams, C., & Zolla-Pazner, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.6994-7000.1994 · Cited by 211
Self-citationA vaccine for HIV type 1: The antibody perspective
Burton, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10018 · Cited by 207
Self-citationMoulard, M., Phogat, S. K., Shu, Y., Labrijn, A. F., Xiao, X., Binley, J. M., Zhang, M.-Y., Sidorov, I. A., Broder, C. C., Robinson, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102562599 · Cited by 204
Self-citationConnor, R. I., Korber, B. T. M., Graham, B. S., Hahn, B. H., Ho, D. D., Walker, B. D., Neumann, A. U., Vermund, S. H., Mestecky, J., Jackson, S., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1552-1576.1998 · Cited by 203
Self-citationHill, C. M., Deng, H., Unutmaz, D., Kewalramani, V. N., Bastiani, L., Gorny, M. K., Zolla-Pazner, S., & Littman, D. R. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6296-6304.1997 · Cited by 199
Self-citationStructural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D
Stanfield, R. L., Gorny, M. K., Williams, C., Zolla-Pazner, S., & Wilson, I. A. (2004) · Structure · doi:10.1016/j.str.2004.01.003 · Cited by 194
Self-citationRodenburg, C. M., Li, Y., Trask, S. A., Chen, Y., Decker, J., Robertson, D. L., Kalish, M. L., Shaw, G. M., Allen, S., Hahn, B. H., et al. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220150217247 · Cited by 181
Gorny, M. K., Williams, C., Volsky, B., Revesz, K., Cohen, S., Polonis, V. R., Honnen, W. J., Kayman, S. C., Krachmarov, C., Pinter, A., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9035-9045.2002 · Cited by 177
Self-citationBinley, J. M., Klasse, P. J., Cao, Y., Jones, I., Markowitz, M., Ho, D. D., & Moore, J. P. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2799-2809.1997 · Cited by 176
Self-citationOsmanov, S. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1327 · Cited by 176
Heyndrickx, L., Janssens, W., Zekeng, L., Musonda, R., Anagonou, S., Van der Auwera, G., Coppens, S., Vereecken, K., De Witte, K., Van Rampelbergh, R., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.363-370.2000 · Cited by 167
Salminen, M. O., Koch, C., Sanders-Buell, E., Ehrenberg, P. K., Michael, N. L., Carr, J. K., Burke, D. S., & McCutchan, F. E. (1995) · Virology · doi:10.1006/viro.1995.1548 · Cited by 166
Precious, H. M., Günthard, H. F., Wong, J. K., D'Aquila, R. T., Johnson, V. A., Kuritzkes, D. R., Richman, D. D., & Brown, A. J. L. (2000) · AIDS · doi:10.1097/00002030-200001070-00004 · Cited by 163
Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5
Purtscher, M., Trkola, A., Grassauer, A., Schulz, P. M., Klima, A., Döpper, S., Gruber, G., Buchacher, A., Muster, T., & Katinger, H. (1996) · AIDS · doi:10.1097/00002030-199606000-00003 · Cited by 162
Self-citationZwick, M. B., Wang, M., Poignard, P., Stiegler, G., Katinger, H., Burton, D. R., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12198-12208.2001 · Cited by 160
Self-citationParker, C. E., Deterding, L. J., Hager-Braun, C., Binley, J. M., Schülke, N., Katinger, H., Moore, J. P., & Tomer, K. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10906-10911.2001 · Cited by 159
Self-citationKostrikis, L. G., Cao, Y., Ngai, H., Moore, J. P., & Ho, D. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.445-458.1996 · Cited by 158
Srivastava, I. K., Stamatatos, L., Kan, E., Vajdy, M., Lian, Y., Hilt, S., Martin, L., Vita, C., Zhu, P., Roux, K. H., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11244-11259.2003 · Cited by 147
Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., Habib, R. E., Klein, M. C. A., Lazzarin, A., et al. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200750054756 · Cited by 147
Sharon, M., Kessler, N., Levy, R., Zolla‐Pazner, S., Görlach, M., & Anglister, J. (2003) · Structure · doi:10.1016/s0969-2126(03)00011-x · Cited by 145
Self-citationImmunogenicity and Protective Efficacy of Oligomeric Human Immunodeficiency Virus Type 1 gp140
Earl, P. L., Sugiura, W., Montefiori, D. C., Broder, C. C., Lee, S. A., Wild, C. T., Lifson, J. D., & Moss, B. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.645-653.2001 · Cited by 140
Genetic Subtypes, Humoral Immunity, and Human Immunodeficiency Virus Type 1 Vaccine Development
Moore, J. P., Parren, P. W. H. I., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5721-5729.2001 · Cited by 134
Self-citationMoore, J. P., McCutchan, F. E., Poon, S. W., Mascola, J. R., Liu, J., Cao, Y., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8350-8364.1994 · Cited by 133
McCutchan, F. E., Carr, J. K., Bajani, M. D., et al. (1999) · Virology · doi:10.1006/viro.1998.9505 · Cited by 125
The antibody response in HIV-1 infection.
Burton, D. R., & Montefiori, D. C. (1997) · PubMed · Cited by 125
Self-citationCoëffier, E., Clément, J.-M., Cussac, V., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00267-x · Cited by 123
Mascola, J. R., Louder, M. K., VanCott, T. C., Sapan, C. V., Lambert, J. S., Muenz, L. R., Bunow, B. J., Birx, D. L., & Robb, M. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7198-7206.1997 · Cited by 118
An Infectious DNA Clone of HIV Type 1 Subtype C
Mochizuki, N., Otsuka, N., Matsuo, K., Shiino, T., Kojima, A., Kurata, T., Sakai, K., Yamamoto, N., Isomura, S., Dhole, T. N., et al. (1999) · AIDS Research and Human Retroviruses · doi:10.1089/088922299310223 · Cited by 112
Mascola, J. R., Louder, M. K., Winter, C., Prabhakara, R., Rosa, S. C. D., Douek, D. C., Hill, B. J., Gabuzda, D. H., & Roederer, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4810-4821.2002 · Cited by 108
Nagashima, K. A., Thompson, D. A. D., Rosenfield, S. I., Maddon, P. J., Dragic, T., & Olson, W. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/319284 · Cited by 105
TILLEY, S. A., Honnen, W. J., RACHO, M. E., Chou, T., & PINTER, A. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.461 · Cited by 102
Neutralizing antiviral antibody responses
Zinkernagel, R. M., Lamarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A. F., McCoy, K. D., Fehr, T. H., Bachmann, M. F., Kalinke, U., & Hengartner, H. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)79001-3 · Cited by 99
McKeating, J. A., Cordell, J. L., Dean, H. J., & Balfe, P. (1992) · Virology · doi:10.1016/0042-6822(92)90249-o · Cited by 97
Multivariate analysis of human immunodeficiency virus type 1 neutralization data
Nyambi, P. N., Nkengasong, J. N., Lewi, P. J., Andries, K., Janssens, W., Fransen, K., Heyndríckx, L., Piot, P., & van der Groen, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6235-6243.1996 · Cited by 94
Zolla‐Pazner, S., O'Leary, J., Burda, S., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3807-3815.1995 · Cited by 87
Self-citationPugach, P., Kuhmann, S. E., Taylor, J., Marozsan, A. J., Snyder, A., Ketas, T. J., Wolinsky, S. M., Korber, B., & Moore, J. P. (2004) · Virology · doi:10.1016/j.virol.2003.12.012 · Cited by 84
Self-citationLiang, X., Munshi, S., Shendure, J., Mark, G., Davies, M. E., Freed, D. C., Montefiori, D. C., & Shiver, J. W. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00125-5 · Cited by 84
Laal, S., Burda, S. T., Górny, M. K., Karwowska, S., Buchbinder, A., & Zolla‐Pazner, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4001-4008.1994 · Cited by 78
Self-citationLi, A., Katinger, H. W. D., Posner, M. R., Cavacini, L. A., Zolla‐Pazner, S., Górny, M. K., Sodroski, J., Chou, T., Baba, T. W., & Ruprecht, R. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3235-3240.1998 · Cited by 78
Self-citationAbrahamyan, L. G., Markosyan, R. M., Moore, J. P., Cohen, F., & Melikyan, G. B. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5829-5836.2003 · Cited by 75
Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein
Richardson, T. M., Stryjewski, B. L., Broder, C. C., Hoxie, J. A., Mascola, J. R., Earl, P. L., & Doms, R. W. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.753-762.1996 · Cited by 72
McCutchan, F. E., Artenstein, A. W., Sanders‐Buell, E., Salminen, M. O., Carr, J. K., Mascola, J. R., Yu, X., Nelson, K. E., Khamboonruang, C., Schmitt, D., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3331-3338.1996 · Cited by 71
LI, A., Baba, T. W., Sodroski, J., Zolla‐Pazner, S., Górny, M. K., ROBINSON, J., Posner, M. R., Katinger, H. W. D., Barbas, C. F., Burton, D. R., et al. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.647 · Cited by 63
Self-citationXu, W., Smith-Franklin, B. A., Li, P., Wood, C. A., He, J., Du, Q., Bhat, G. J., Kankasa, C., Katinger, H. W. D., Cavacini, L. A., et al. (2001) · PubMed · Cited by 57
Self-citationNyambi, P. N., Nadas, A. J., Mbah, H. A., Burda, S. T., Williams, C. A. U., Górny, M. K., & Zolla‐Pazner, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10670-10680.2000 · Cited by 49
Self-citationVerrier, F., Nadas, A. J., Górny, M. K., & Zolla‐Pazner, S. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9177-9186.2001 · Cited by 48
Self-citationZolla‐Pazner, S., Górny, M. K., Nyambi, P. N., VanCott, T. C., & Nadas, A. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4042-4051.1999 · Cited by 44
Self-citationKUIKEN, C. L., Lukashov, V. V., Baan, E., Dekker, J. T., Leunissen, J. A. M., & Goudsmit, J. (1996) · AIDS · doi:10.1097/00002030-199601000-00005 · Cited by 39
Beaumont, T., Quakkelaar, E. D., van Nuenen, A. C., Pantophlet, R. A., & Schuitemaker, H. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5651-5657.2004 · Cited by 36
Kitabwalla, M., Ferrantelli, F., Wang, T., Chalmers, A., Katinger, H. W. D., Stiegler, G. M., Cavacini, L. A., Chou, T., & Ruprecht, R. M. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203762688630 · Cited by 31
Self-citationPainter, S. L., Biek, R., Holley, D. C., & Poss, M. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8448-8461.2003 · Cited by 7
Cited by
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Self-citationLi, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Self-citationDistribution and three-dimensional structure of AIDS virus envelope spikes
Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 780
Metadata
- Authors
- Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, C. J., & Burton, D. R.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2004-12
- Volume
- 78
- Issue
- 23
- Pages
- 13232-13252
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2157210912
- Cited by
- 705
- References
- 110
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.